Corbus Pharmaceuticals Provides Management Team Updates

NEXT STORY
Athenex宣佈委任Daniel Von Hoff博士為Axis Therapeutics Limited的科學顧問委員會主席
PREV STORY
Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ChemoCentryx Reports First Quarter 2017 Financial Results

-- Phase III clinical trial of avacopan for the treatment of ANCA Vasculitis underway ...

author_avatar
NASDAQ Market News

Emergent BioSolutions Announces Commencement of When Issued Trading of Aptevo Common Stock

GAITHERSBURG, Md., July 20, 2016 (GLOBE NEWSWIRE) -- In connection with the spin-off of ...

author_avatar
NASDAQ Market News

USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells

MONT-SAINT-GUIBERT, Belgium, March 16, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

author_avatar
NASDAQ Market News